Not applicableLooking for participantsNCT04028531What this trial is testingUnderstanding Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Dana-Farber Cancer Institute 2,750
Testing effectiveness (Phase 2)Study completedNCT00002547What this trial is testingChemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes Barbara Ann Karmanos Cancer Institute 280
Testing effectiveness (Phase 2)Study completedNCT01297543What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+1 more Cellerant Therapeutics 45
Testing effectiveness (Phase 2)Ended earlyNCT01612988What this trial is testingTreatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLLWho this might be right forB-cell Chronic Lymphocytic Leukemia (B-CLL) French Innovative Leukemia Organisation 74
Testing effectiveness (Phase 2)Study completedNCT00481091What this trial is testingABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia AbbVie 60
Early research (Phase 1)Study completedNCT02081378What this trial is testingA Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALLWho this might be right forChronic Myelogenous LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia Novartis Pharmaceuticals 326
Testing effectiveness (Phase 2)Study completedNCT02530515What this trial is testingEx Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic LeukemiaWho this might be right forAnemiaCancer FatigueChronic Lymphocytic Leukemia+11 more M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT02332980What this trial is testingPembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin LymphomasWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+20 more Mayo Clinic 65
Large-scale testing (Phase 3)Study completedNCT01516580What this trial is testingIntergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk PatientsWho this might be right forB-cell Non Hodgkin LymphomaMature B-cell Leukemia Burkitt-type Gustave Roussy, Cancer Campus, Grand Paris 482
Testing effectiveness (Phase 2)Study completedNCT01181258What this trial is testingPenostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid MalignanciesWho this might be right forNon-Hodgkin LymphomaChronic Lymphocytic Leukemia Masonic Cancer Center, University of Minnesota 16
Early research (Phase 1)Study completedNCT00078520What this trial is testingTreatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor CellsWho this might be right forLeukemiaLeukemia, B-Cell, Chronic Baylor College of Medicine 9
Testing effectiveness (Phase 2)UnknownNCT02507479What this trial is testingThiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid MalignanciesWho this might be right forNon Hodgkin LymphomaHodgkin LymphomaChronic Lymphocytic Leukemia+1 more Sheba Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT01497496What this trial is testingOfatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma H. Lee Moffitt Cancer Center and Research Institute 29
Testing effectiveness (Phase 2)Study completedNCT03088878What this trial is testingCirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid MalignanciesWho this might be right forB-cell Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+1 more Oncternal Therapeutics, Inc 95
Large-scale testing (Phase 3)Study completedNCT00354120What this trial is testingThymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic TransplantWho this might be right forAcute Myeloblastic LeukemiaLymphoblastic LeukemiaMyelodysplasia+3 more Gruppo Italiano Trapianto di Midollo Osseo 121
Large-scale testing (Phase 3)Ended earlyNCT01518959What this trial is testingThe Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic DiseasesWho this might be right forChronic Lymphoid Leukemia Semmelweis University 31
Not applicableEnded earlyNCT00176930What this trial is testingStem Cell Transplant for Hematological MalignancyWho this might be right forLeukemia, Myeloid, ChronicAMLLeukemia, Lymphocytic, Acute+6 more Masonic Cancer Center, University of Minnesota 330
Large-scale testing (Phase 3)UnknownNCT00020865What this trial is testingLevofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and NeutropeniaWho this might be right forFever, Sweats, and Hot FlashesInfectionLeukemia+3 more Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00526292What this trial is testingChemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell TransplantWho this might be right forLeukemiaMyelodysplastic Syndromes Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)Ended earlyNCT01035216What this trial is testingA Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)Who this might be right forLeukemia SBI Biotech Co., Ltd. 18